Marizyme, Inc. (MRZM)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Oct 2, 2025
Marizyme Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.18 | 0.65 | 0.23 | 0.21 | 0.2 | - | Upgrade
|
| Revenue Growth (YoY) | -68.96% | 176.60% | 11.04% | 6.67% | - | - | Upgrade
|
| Cost of Revenue | 0.07 | 0.41 | 0.05 | 0.08 | 0.06 | - | Upgrade
|
| Gross Profit | 0.12 | 0.24 | 0.18 | 0.13 | 0.14 | - | Upgrade
|
| Selling, General & Admin | 10.38 | 16.54 | 6.43 | 6.33 | 2.83 | 1.06 | Upgrade
|
| Research & Development | 1.37 | 2.18 | 3.98 | 1.68 | 0.69 | - | Upgrade
|
| Operating Expenses | 12.48 | 20.08 | 13.15 | 8.95 | 5.94 | 1.06 | Upgrade
|
| Operating Income | -12.36 | -19.84 | -12.97 | -8.82 | -5.8 | -1.06 | Upgrade
|
| Interest Expense | -31.99 | -30.11 | -2.78 | -0.12 | -0.05 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 25.82 | 4.98 | 1.6 | -1.4 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -18.53 | -44.97 | -14.15 | -10.33 | -5.85 | -1.06 | Upgrade
|
| Asset Writedown | -14.24 | -14.24 | -24.35 | - | - | - | Upgrade
|
| Other Unusual Items | 17.82 | -6.13 | 0.34 | -0.66 | - | - | Upgrade
|
| Pretax Income | -14.95 | -65.35 | -38.17 | -11 | -5.85 | -1.06 | Upgrade
|
| Net Income | -14.95 | -65.35 | -38.17 | -11 | -5.85 | -1.06 | Upgrade
|
| Net Income to Common | -14.95 | -65.35 | -38.17 | -11 | -5.85 | -1.06 | Upgrade
|
| Shares Outstanding (Basic) | 112 | 45 | 41 | 36 | 26 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 112 | 45 | 41 | 36 | 26 | 20 | Upgrade
|
| Shares Change (YoY) | 162.54% | 11.65% | 13.00% | 36.66% | 33.16% | 196.88% | Upgrade
|
| EPS (Basic) | -0.13 | -1.44 | -0.94 | -0.31 | -0.22 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.13 | -1.44 | -0.94 | -0.31 | -0.22 | -0.05 | Upgrade
|
| Gross Margin | 63.27% | 36.99% | 76.74% | 61.79% | 70.43% | - | Upgrade
|
| Operating Margin | -6741.22% | -3072.44% | -5556.59% | -4195.09% | -2941.93% | - | Upgrade
|
| Profit Margin | -8152.89% | -10118.60% | -16346.18% | -5230.16% | -2964.99% | - | Upgrade
|
| EBITDA | -11.82 | -19 | -12.13 | -8.78 | -5.21 | - | Upgrade
|
| D&A For EBITDA | 0.55 | 0.84 | 0.84 | 0.04 | 0.59 | - | Upgrade
|
| EBIT | -12.36 | -19.84 | -12.97 | -8.82 | -5.8 | -1.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.